Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Chemoradiotherapy in Locally Advanced Cervical Cancer
NCT06353061Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of liquid metformin (Aspargo Labs) in Cervical Cancer (CC) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Improvement in Hypoxic Index measured by CAIX PET at 1 week. Started Apr 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06353061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06353061.